The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Endogenous kynurenines as targets for drug discovery and development
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Neuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 948
Self-citationHilmas, C., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 859
Pfefferkorn, E. R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.908 · Cited by 854
Perkins, M. N., & Stone, T. W. (1982) · Brain Research · doi:10.1016/0006-8993(82)91048-4 · Cited by 849
Self-citationQuinolinic acid: a potent endogenous excitant at amino acid receptors in CNS
Stone, T. W., & Perkins, M. N. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90587-2 · Cited by 751
Self-citationMorphogen gradient interpretation
Gurdon, J. B., & Bourillot, P.-Y. (2001) · Nature · doi:10.1038/35101500 · Cited by 748
HEYES, M. P., SAITO, K., CROWLEY, J. S., DAVIS, L. E., DEMITRACK, M. A., DER, M., DILLING, L. A., ELIA, J., KRUESI, M. J. P., LACKNER, A., et al. (1992) · Brain · doi:10.1093/brain/115.5.1249 · Cited by 680
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 538
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
Beal, M., Ferrante, R., Swartz, K., & Kowall, N. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01649.1991 · Cited by 499
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
Erhardt, S., Blennow, K., Nordin, C., Skogh, E., Lindström, L. H., & Engberg, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02242-x · Cited by 471
Okuda, S., Nishiyama, N., Saito, H., & Katsuki, H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010299.x · Cited by 462
Birch, P. J., Grossman, C. J., & Hayes, A. G. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90367-6 · Cited by 318
Glutamate signalling in non-neuronal tissues
Skerry, T. M., & Genever, P. G. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01642-4 · Cited by 307
Kynurenines in the CNS: from endogenous obscurity to therapeutic importance
Stone, T. W. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00032-0 · Cited by 306
Self-citationGlutamate antagonists limit tumor growth
Rzeski, W., Turski, L., & Ikonomidou, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091113598 · Cited by 287
Tryptophan degradation and immune activation in Alzheimer's disease
Widner, B., Leblhuber, F., Walli, J., Tilz, G. P., Demel, U., & Fuchs, D. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050029 · Cited by 286
Presynaptic kynurenate‐sensitive receptors inhibit glutamate release
Carpenedo, R., Pittaluga, A., Cozzi, A., Attucci, S., Galli, A., Raiteri, M., & Moroni, F. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01592.x · Cited by 254
Hansson, O., Petersén, Å., Leist, M., Nicotera, P., Castilho, R. F., & Brundin, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8727 · Cited by 228
Behan, W. M. H., McDonald, M., Darlington, L. G., & Stone, T. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702940 · Cited by 225
Self-citationKynurenic acid concentrations are reduced in Huntington's disease cerebral cortex
Flint Beal, M., Matson, W. R., Storey, E., Milbury, P., Ryan, E. A., Ogawa, T., & Bird, E. D. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90191-m · Cited by 218
Thomas, S. R., Mohr, D., & Stocker, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36645-0 · Cited by 212
Tryptophan Nutrition and Metabolism: An Overview
Peters, J. C. (1991) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4684-5952-4_32 · Cited by 211
Röver, S., Cesura, A. M., Huguenin, P., Kettler, R., & Szente, A. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970467t · Cited by 211
Stone, T. W. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01451-6 · Cited by 211
Self-citationGoldstein, L. E., Leopold, M. C., Huang, X., Atwood, C. S., Saunders, A. J., Hartshorn, M., Lim, J. T., Faget, K. Y., Muffat, J. A., Scarpa, R. C., et al. (2000) · Biochemistry · doi:10.1021/bi992997s · Cited by 211
Thomas, S. R., & Stocker, R. (1999) · Redox Report · doi:10.1179/135100099101534927 · Cited by 208
Hayes, M. P., Rubinow, D., Lane, C., & Markey, S. P. (1989) · Annals of Neurology · doi:10.1002/ana.410260215 · Cited by 188
3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims.
Schwarcz, R., Okuno, E., White, R. J., Bird, E. D., & Whetsell, W. O. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4079 · Cited by 184
3‐Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum
Guidetti, P., & Schwarcz, R. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00806.x · Cited by 180
Sanni, L. A., Thomas, S. R., Tattam, B. N., Moore, D. E., Chaudhri, G., Stocker, R., & Hunt, N. H. (1998) · Europe PMC (PubMed Central) · Cited by 178
Whetsell, W. O., & Schwarcz, R. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90609-5 · Cited by 175
Patton, A. J., Genever, P. G., Birch, M. A., Suva, L. J., & Skerry, T. M. (1998) · Bone · doi:10.1016/s8756-3282(98)00061-1 · Cited by 175
Apoptosis in the in Vivo Mammalian Forebrain
Dikranian, K., Ishimaru, M. J., Tenkova, T., Labruyere, J., Qin, Y. Q., Ikonomidou, C., & Olney, J. W. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0411 · Cited by 163
Cozzi, A., Carpenedo, R., & Moroni, F. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199907000-00007 · Cited by 159
Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease
Pearson, S. J., & Reynolds, G. P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90749-w · Cited by 155
Quinolinic Acid Production by Macrophages Stimulated with IFN-γ, TNF-α, and IFN-α
PEMBERTON, L. A., KERR, S. J., SMYTHE, G., & BREW, B. J. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.589 · Cited by 149
Quinolinate neurotoxicity in cortical cell culture
Kim, J. P., & Choi, D. W. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90066-2 · Cited by 147
Leeson, P. D., Baker, R., Carling, R. W., et al. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00108a002 · Cited by 146
Henderson, G., Johnson, J. W., & Ascher, P. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018288 · Cited by 142
Heyes, M. P., Brew, B. J., Saito, K., Quearry, B. J., Price, R. W., Lee, K., Bhalla, R. B., Der, M. G., & Markey, S. P. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90214-6 · Cited by 140
Interferons and indoleamine 2,3-dioxygenase: Role in antimicrobial and antitumor effects
Carlin, J. M., Ozaki, Y., Byrne, G. I., Brown, R. R., & Borden, E. C. (1989) · Cellular and Molecular Life Sciences · doi:10.1007/bf01990503 · Cited by 140
Kerr, S. J., Armati, P. J., Guillemin, G. J., & Brew, B. J. (1998) · AIDS · doi:10.1097/00002030-199804000-00003 · Cited by 132
Neuroactive kynurenines in Lyme borreliasis
HALPERIN, J. J., & Heyes, M. P. (1992) · Neurology · doi:10.1212/wnl.42.1.43 · Cited by 128
Jauch, D., Urbańska, E. M., Guidetti, P., Bird, E. D., Vonsattel, J., Whetsell, W. O., & Schwarcz, R. M. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00280-2 · Cited by 127
Heyes, M. P. (2001) · Brain · doi:10.1093/brain/124.5.1033 · Cited by 126
Potential Target Sites in Peripheral Tissues for Excitatory Neurotransmission and Excitotoxicity
Gill, S., Mueller, R. W., McGuire, P. F., et al. (2000) · Toxicologic Pathology · doi:10.1177/019262330002800207 · Cited by 125
The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine
Eastman, C. L., & Guilarte, T. R. (1990) · Neurochemical Research · doi:10.1007/bf01101711 · Cited by 114
Differential Expression of Glutamate Receptor Subtypes in Rat Pancreatic Islets
Weaver, C. D., Yao, T. L., Powers, A. C., & Verdoorn, T. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12977 · Cited by 113
Moroni, F., Lombardi, G., Moneti, G., & Aldinio, C. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90385-9 · Cited by 109
Moroni, F., Luzzi, S., Franchi‐Micheli, S., & Zilletti, L. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90229-6 · Cited by 108
Chiarugi, A., Meli, E., & Moroni, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00335.x · Cited by 108
In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum
Santamaría, A., Jiménez-Capdeville, M. E., Camacho‐Morales, A., Rodríguez-Martínez, E., Flores, A., & Galván‐Arzate, S. (2001) · Neuroreport · doi:10.1097/00001756-200108280-00020 · Cited by 107
Speciale, C., Wu, H., Cini, M., Marconi, M., Varasi, M., & Schwarcz, R. M. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00613-9 · Cited by 104
Energetic Dysfunction in Quinolinic Acid‐Lesioned Rat Striatum
Bordelon, Y. M., Chesselet, M., Nelson, D., Welsh, F. A., & Erecińska, M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041629.x · Cited by 100
Chiarugi, A., Cozzi, A., Ballerini, C., Massacesi, L., & Moroni, F. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00504-2 · Cited by 100
Poliovirus induces indoleamine‐2,3‐dioxygenase and quinolinic acid synthesis in macaque brain
Heyes, M. P., Saito, K., Jacobowitz, D. M., Markey, S. P., Takikawa, O., & Vickers, J. H. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.11.1322853 · Cited by 98
Early kynurenergic impairment in Huntington's Disease and in a transgenic animal model
Guidetti, P., Reddy, P. H., Tagle, D. A., & Schwarcz, R. M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00956-3 · Cited by 97
Guidetti, P., Eastman, C. L., & Schwarcz, R. M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65062621.x · Cited by 94
Nicotinylalanine Increases the Formation of Kynurenic Acid in the Brain and Antagonizes Convulsions
Russi, P., Alesiani, M., Lombardi, G., Davolio, P. L., Pellicciari, R., & Moroni, F. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10097.x · Cited by 89
Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid
Harris, C. A., Miranda, A., Tanguay, J., Boegman, R. J., Beninger, R. J., & Jhamandas, K. H. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701834 · Cited by 89
Kelly, R. W., Amato, F., & Seamark, R. F. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)90732-0 · Cited by 84
Chiarugi, A., Carpenedo, R., & Moroni, F. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020692.x · Cited by 84
Sinz, E. H., Kochanek, P. M., Heyes, M. P., Wisniewski, S. R., Bell, M. J., Clark, R. S. B., DeKosky, S. T., Blight, A. R., & Marion, D. W. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199806000-00002 · Cited by 83
Baran, H., Cairns, N. J., Lubec, B., & Lübec, G. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00173-7 · Cited by 83
Wu, H., Guidetti, P., Goodman, J. H., Varasi, M., Ceresoli‐Borroni, G., Speciale, C., Scharfman, H. E., & Schwarcz, R. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00030-0 · Cited by 80
Sekkaï, D., Guittet, O., Lemaire, G., Tenu, J., & Lepoivre, M. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.9913 · Cited by 79
Degradation of Tryptophan in Neurodegenerative Disorders
Widner, B., Leblhuber, F., Walli, J., Tilz, G. P., Demel, U., & Fuchs, D. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4709-9_19 · Cited by 74
Savvateeva, E. V., Popov, A. V., Камышев, Н. Г., Bragina, J. V., Heisenberg, M., Senitz, D., Kornhuber, J., & Riederer, P. F. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070080 · Cited by 74
Dang, Y.-H., Dale, W. E., & Brown, O. R. (2000) · Free Radical Biology & Medicine · doi:10.1016/s0891-5849(99)00272-5 · Cited by 72
León, J., Vives, F., Crespo, E., Camacho, E., Espinosa, A., Gallo, M. Á., Escames, G., & Acuña-Castroviejo, D. (1998) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1998.00203.x · Cited by 70
Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia
Sardar, A. M., & Reynolds, G. P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11324-p · Cited by 67
Behan, W. M. H., & Stone, T. W. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704613 · Cited by 65
Self-citationItzstein, C., Espinosa, L., Delmas, P. D., & Chenu, C. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2097 · Cited by 63
Delayed Increases in Regional Brain Quinolinic Acid Follow Transient Ischemia in the Gerbil
Heyes, M. P., & Nowak, T. S. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.119 · Cited by 62
Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity
Connick, J. H., Heywood, G. C., Sills, G. J., Thompson, G., Brodie, M. J., & Stone, T. W. (1992) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(92)90017-e · Cited by 61
Self-citationIncrease in Kynurenic Acid in Huntington's Disease Motor Cortex
Connick, J. H., Carla�, V., Moroni, F., & Stone, T. W. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb02552.x · Cited by 58
Self-citationQuinolinic acid and the kynurenines
Holmes, G. L. (1990) · Journal of Epilepsy · doi:10.1016/0896-6974(90)90063-5 · Cited by 57
Takano, K., Tatlisumak, T., Formato, J. E., Carano, R. A. D., Bergmann, A. G., Pullan, L. M., Bare, T. M., Sotak, C. H., & Fisher, M. (1997) · Stroke · doi:10.1161/01.str.28.6.1255 · Cited by 57
Wu, H., Lee, S.-C., & Schwarcz, R. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00024-8 · Cited by 55
Ghorayeb, I., Puschban, Z., Fernagut, P., Scherfler, C., Rouland, R., Wenning, G. K., & Tison, F. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7535 · Cited by 54
Walsh, J. L., Todd, W. P., Carpenter, B. K., & Schwarcz, R. M. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90279-e · Cited by 51
Moffett, J., Els, T., Espey, M., Walter, S. A., Streit, W. J., & Namboodiri, M. A. A. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6365 · Cited by 50
Saletu, B., Schjerve, M., GR�NBERGER, J., Schanda, H., & Arnold, O. (1977) · Journal of Neural Transmission · doi:10.1007/bf01252962 · Cited by 48
Köhler, C., Eriksson, L., Flood, P., Hardie, J., Okuno, E., & Schwarcz, R. M. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-03-00975.1988 · Cited by 47
Abnormal tryptophan metabolism and experimental diabetes by xanthurenic acid (XA).
Kotake, Y., Ueda, T., Mori, T., et al. (1975) · PubMed · Cited by 44
Baron, B. M., Harrison, B. L., McDonald, I. A., Meldrum, B. S., Palfreyman, M. G., Salituro, F. G., Siegel, B. W., Slone, A. L., Turner, J. P., & White, H. S. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10939-7 · Cited by 43
Elucidation of a Novel Polypeptide Cross-Link Involving 3-Hydroxykynurenine
Aquilina, J. A., Carver, J. A., & Truscott, R. J. W. (1999) · Biochemistry · doi:10.1021/bi990458h · Cited by 43
Harrison, B. L., Baron, B. M., Cousino, D. M., & McDonald, I. A. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00174a005 · Cited by 42
[3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype
Ihara, M., Yamanaka, R., Ohwaki, K., Ozaki, S., Fukami, T., Ishikawa, K., Towers, P., & Yano, M. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00670-3 · Cited by 40
Chiarugi, A., & Moroni, F. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00048-9 · Cited by 40
Kynurenic Acid Influences the Respiratory Parameters of Rat Heart Mitochondria
Baran, H., Staniek, K., Kepplinger, B., Gille, L., Stolze, K., & Nohl, H. (2001) · Pharmacology · doi:10.1159/000056082 · Cited by 39
Franchi, A. M., Gimeno, M. F., Cardinali, D. P., & Vacas, M. I. (1987) · Brain Research · doi:10.1016/0006-8993(87)90311-8 · Cited by 39
Effect of Dexamethasone Treatment on Maturational Changes in the NMDA Receptor in Sheep Brain
Mcgowan, J., Sysyn, G., Petersson, K., Sadowska, G., Mishra, O., Delivoria-Papadopoulos, M., & Stonestreet, B. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-19-07424.2000 · Cited by 38
Scharfman, H. E., Hodgkins, P., Lee, S.-C., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00690-4 · Cited by 38
Autoradiographic localization of tryptamine binding sites in the rat and dog central nervous system
McCormack, J., Beitz, A. J., & Larson, A. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-01-00094.1986 · Cited by 37
Neurotoxic effect induced by quinolinic acid in dissociated cell culture of mouse hippocampus
Хаспеков, Л. Г., Kida, E., Victorov, I. V., & Mossakowski, M. J. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490220207 · Cited by 36
Kulagowski, J. J. (1996) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.6.10.1069 · Cited by 36
Espey, M., Moffett, J. R., & Namboodiri, A. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.2.199 · Cited by 36
Increased kynurenic acid in the brain after neonatal asphyxia
Baran, H., Kepplinger, B., Herrera‐Marschitz, M., Stolze, K., Lübec, G., & Nohl, H. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01215-2 · Cited by 35
Simonati, A., Tosati, C., Rosso, T., Piazzola, E., & Rizzuto, N. (1999) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19990615)45:6<359::aid-jemt4>3.0.co;2-d · Cited by 34
Blight, A. R., Leroy, E. C., & Heyes, M. P. (1997) · Journal of Neurotrauma · doi:10.1089/neu.1997.14.89 · Cited by 34
Dong-Ruyl, L., Sawada, M., & Nakano, K. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00120-7 · Cited by 33
Chapman, A. G., Dürmüller, N., Harrison, B. L., et al. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00713-h · Cited by 32
Espey, M., Tang, Y., Morse, H., Moffett, J., & Namboodiri, M. A. A. (1996) · AIDS (London) · doi:10.1097/00002030-199602000-00004 · Cited by 32
Guidetti, P., Wu, H., & Schwarcz, R. M. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7284 · Cited by 32
Quinolinic Acid and the Kynurenines
Stone, T. W. (1988) · Medical Entomology and Zoology · Cited by 32
Self-citationStudies on the Urinary Excretion of Xanthurenic Acid in Diabetics
Hattori, M., Kotake, Y., Kotake, Y., Otsuka, H., & Shibata, Y. (1984) · De Gruyter eBooks · doi:10.1515/9783111641546-047 · Cited by 32
Brady, R. J., & Swann, J. W. (1988) · Epilepsy Research · doi:10.1016/0920-1211(88)90013-7 · Cited by 30
Kazda, H., Taylor, N., Healy, D., & Walker, D. W. (1998) · Pediatric Research · doi:10.1203/00006450-199809000-00017 · Cited by 29
Neonatal Asphyxia in Rats: Acute Effects on Cerebral Kynurenine Metabolism
Ceresoli‐Borroni, G., & Schwarcz, R. M. (2001) · Pediatric Research · doi:10.1203/00006450-200108000-00011 · Cited by 28
Fitzgerald‐Hughes, D., Muirhead, K. M., & Botting, N. P. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00318-7 · Cited by 27
Stone, T. W. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90414-4 · Cited by 27
Self-citation4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase
Giordani, A., Pevarello, P., Cini, M., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00517-4 · Cited by 27
Kynurenine metabolism in vitamin-B-6-deficient rat liver after tryptophan injection
Takeuchi, F., & Shibata, Y. (1984) · Biochemical Journal · doi:10.1042/bj2200693 · Cited by 25
MacGibbon, G. A., Hamilton, L. C., Crocker, S. F., Costain, W. J., Murphy, K. M., Robertson, H. A., & Denovan‐Wright, E. M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10100 · Cited by 23
Nicholls, T., Nitsos, I., & Walker, D. W. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70391-1 · Cited by 23
Control of Extracellular Matrix Degradation by Interferon-γ
Varga, J., Yufit, T., Hitraya, E. G., & Brown, R. R. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0381-7_23 · Cited by 22
Luthman, J., Rades�ter, A. C., & �berg, C. (1998) · Amino Acids · doi:10.1007/bf01345273 · Cited by 22
Modulation and Function of Kynurenic Acid in the Immature Rat Brain
Schwarcz, R. M., Ceresoli‐Borroni, G., Wu, H., Rassoulpour, A., Pöeggeler, B., Hodgkins, P., & Guidetti, P. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4709-9_17 · Cited by 21
Transcription of the Huntington disease gene during the quinolinic acid excitotoxic cascade
Carlock, L. R., Walker, P. D., Shan, Y., & Gutridge, K. (1995) · Neuroreport · doi:10.1097/00001756-199505300-00012 · Cited by 18
Issa, F., Kirch, D. G., Gerhardt, G. A., et al. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90070-1 · Cited by 17
Namboodiri, A., Venkateshan, C. N. S., Narayanan, R., Blinder, K., Moffett, J. R., Gajdusek, D., Gravell, M., & Gibbs, C. J. (1996) · Journal of Neurovirology · doi:10.3109/13550289609146910 · Cited by 17
Boireau, A., Malgouris, C., Burgevin, M., et al. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00780-6 · Cited by 17
Maloney, E. M., Morgan, O. C., Widner, B., Werner, E. R., & Fuchs, D. (2000) · The Journal of Infectious Diseases · doi:10.1086/315483 · Cited by 17
Jackson, P., Davenport, T. W., García, L. L., et al. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00544-0 · Cited by 13
Cardiovascular actions of kynuramine and 5-hydroxykynuramine in pithed rats
Charlton, K. G., Johnson, T. D., Hamed, A. T., & Clarke, D. E. (1983) · Journal of Neural Transmission · doi:10.1007/bf01248993 · Cited by 12
Cited by
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,078
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Metadata
- Authors
- Stone, T. W., & Darlington, L. G.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-08
- Volume
- 1
- Issue
- 8
- Pages
- 609-620
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1964709968
- Cited by
- 768
- References
- 129
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.